Literature DB >> 18577893

Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey.

Ryuichi Suemitsu1, Masafumi Yamaguchi, Sadanori Takeo, Kaoru Ondo, Hitoshi Ueda, Ichiro Yoshino, Yoshihiko Maehara.   

Abstract

BACKGROUND: Surgery for elderly patients, especially those over 80 years old, with primary lung neoplasms is a relatively common treatment according to the increasing elderly population. We reviewed our experiences to evaluate surgical outcomes in over-80-year-old patients with nonsmall cell lung cancer (NSCLC). PATIENTS AND METHODS: We reviewed and analyzed the clinical records of 146 consecutive over-80-year-old patients (Group 1) and 926 control patients (65 years old and younger) (Group 2) with NSCLC who underwent surgical resections from 1981 to 2006.
RESULTS: The mean ages of Group 1 and Group 2 were 82.6 and 56.2 years old, respectively. The ratio of the clinical and pathological Stage I was higher than the Stages II-IV in Group 1, and that of pathological Stage III was higher in Group 2. Segmental and wedge resection were selected more frequently in Group 1, otherwise, pneumonectomy and lobectomy were selected more frequently in Group 2. The ratio of squamous cell carcinoma was higher in Group 1 than in Group 2. When we divided the time of surgeries into decades, the 1980s, 1990s, and 2000s, the ratio of elder to younger patients was clearly increased according to era: 6.6%, 13.7%, and 18.8%. Furthermore, incomplete operation cases were significantly decreased in the two groups. There was no difference of overall survival in either. When examined for overall survival, except for patients with incomplete resection, there was no significant difference between the two groups.
CONCLUSIONS: Surgery is the convenient treatment for elderly NSCLC patients, especially, for those who can undergo complete resection.

Entities:  

Mesh:

Year:  2008        PMID: 18577893

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  7 in total

1.  A model for morbidity after lung resection in octogenarians.

Authors:  Mark F Berry; Mark W Onaitis; Betty C Tong; David H Harpole; Thomas A D'Amico
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-26       Impact factor: 4.191

Review 2.  Surgical treatment of non-small-cell lung cancer in octogenarians.

Authors:  Miguel Guerra; Paulo Neves; José Miranda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-08

3.  Prognostic factors for elderly patients with primary malignant bone and soft tissue tumors.

Authors:  Tadashi Iwai; Manabu Hoshi; Jun Takada; Naoto Oebisu; Masanari Aono; Masatsugu Takami; Makoto Ieguchi; Hiroaki Nakamura
Journal:  Oncol Lett       Date:  2015-06-29       Impact factor: 2.967

4.  SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.

Authors:  Dongtao Yin; Yan Jia; Yuanzi Yu; Malcolm V Brock; James G Herman; Chao Han; Xiaomo Su; Yang Liu; Mingzhou Guo
Journal:  Discov Med       Date:  2012-07       Impact factor: 2.970

5.  Lobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.

Authors:  O Senbaklavaci
Journal:  Int Surg       Date:  2014 Jul-Aug

6.  Does age over 80 years have to be a contraindication for lung cancer surgery-a nationwide database study.

Authors:  Pierre-Benoit Pagès; Anne-Sophie Mariet; Arnaud Pforr; Jonathan Cottenet; Leslie Madelaine; Halim Abou-Hanna; Alain Bernard; Catherine Quantin
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

7.  Assessing Survival and Grading the Severity of Complications in Octogenarians Undergoing Pulmonary Lobectomy.

Authors:  Andrew Feczko; Elizabeth McKeown; Jennifer L Wilson; Brian E Louie; Ralph W Aye; Jed A Gorden; Eric Vallières; Alexander S Farivar
Journal:  Can Respir J       Date:  2017-02-08       Impact factor: 2.409

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.